Incidence and management of condylomata acuminata by French general physicians;Incidence et prise en charge des condylomes acuminés externes en médecine générale

Annales de Dermatologie et de Venereologie

Volumn 129, Issue 8-9, 2002, Pages 991-996

  Lukasiewicz, E ^a   Aractingi, S ^b   Flahault, A ^a  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMITROLE; FLUOROURACIL; PODOPHYLLIN; PODOPHYLLOTOXIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONDYLOMA ACUMINATUM; CRYOTHERAPY; DIAGNOSTIC ERROR; ELECTROCOAGULATION; EPIDEMIOLOGICAL DATA; FEMALE; FRANCE; GENERAL PRACTICE; HUMAN; INCIDENCE; LASER; MAJOR CLINICAL STUDY; MALE; SEXUALLY TRANSMITTED DISEASE; WART VIRUS;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; AMINOQUINOLINES; COHORT STUDIES; CONDYLOMATA ACUMINATA; FAMILY PRACTICE; FEMALE; FRANCE; HUMANS; INTERFERON INDUCERS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PENILE DISEASES; PERINEUM; PODOPHYLLIN; PODOPHYLLOTOXIN; PROSPECTIVE STUDIES; VULVAR DISEASES;

EID: 16744366633     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Handsfield HH. Clinical presentation and natural course of anogenital warts. Am J Med 1997;102:16-20.
2. Gross G, Ikenberg H, Gissmann L, Hagedorn M. Papillomavirus infection of the anogenital region: Correlation between histology, clinical picture and virus type. J Invest Dermatol 1985;85:147-52.
3. Syrjänen KJ. Long term consequences of genital HPV infections in women. Ann Med 1992;24:233-45.
4. Daling JR, Sherman KJ. Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix. IARC Sci Publ 1992;119:223-41.
5. Sigurgeirsson B, Lindelof B, Eklund G. Condylomata acuminata and risk of cancer: An epidemiological study. BMJ 1991;303:341-4.
6. Kjaer SK. Risk factors for cervical neoplasia in Denmark. APMIS Suppl 1998;80:1-41.
7. Friis S, Kjaer SK, Frisch M, Mellemkjaer L, Olsen JH. Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for condylomata acuminata. J Infect Dis 1997;175: 743-8.
8. Chuang TY. Condylomata acuminata (genital warts). An epidemiologic view. J Am Acad Dermatol 1987;16:376-84.
9. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
10. Chuang TY, Perry HO, Kurland LT, Ilstrup DM. Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features. Arch Dermatol 1984;120:469-75.
11. CDC. Condyloma acuminatum - United States, 1966-1981. MMWR Morb Mortal Wkly Rep 1983;32:306-8.
12. CDC. Nonreported sexually transmitted diseases - United States. MMWR Morb Mortal Wkly Rep 1979;28:61-3.
13. Voog E, Bolmstedt A, Olofsson S, Ryd W, Lowhagen GB. Human papilloma virus infection among women attending an STD clinic correlated to reason for attending, presence of clinical signs, concomitant infections and abnormal cytology. Acta Derm Venereol 1995;75:75-8.
14. Simms I, Fairley CK. Epidemiology of genital warts in England and Wales: 1971 to 1994. Genitourin Med 1997;73:365-7.
15. Annual Report of the Chief Medical Officer of the Department of Health and Social Security, 1979: Sexually transmitted diseases. Br J Vener Dis 1981;57:402-5.
16. CDSC. Sexually transmitted diseases quarterly report: Genital warts and genital herpes simplex virus infection in England and Wales. Commun Dis Rep CDR Wkly 1996;6:304-5.
17. CDSC. Sexually transmitted diseases quarterly report: anogenital warts and anogenital herpes simplex virus infection in England and Wales. Commun Dis Rep CDR Wkly 2000;10:230-2.
18. Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001;358:1851-4.
19. Noone A, Chalmers J, Young H. La surveillance des infections sexuellement transmissibles en Ecosse. Eurosurveillance 1998;3:65-8.
20. Giulani M, Suligoi B. La surveillance sentinelle des maladies sexuellement transmissibles en Italie. Eurosurveillance 1998;3:55-8.
21. Hippelainen M, Syrjanen S, Koskela H, Pulkkinen J, Saarikoski S, Syrjanen K. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: A study on Finnish conscripts. Sex Transm Dis 1993;20:321-8.
22. Von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000;76:162-8.
23. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal diseases). National guideline for the management of anogenital warts. Sex Transm Inf 1999;75:S71-5. (Mise à jour 2001 http://www.agum.org.uk/ceg/ draft_warto401.htm).
24. Boussard E, Flahault A, Vibert JF, Valleron AJ. Sentiweb: French communicable disease surveillance on the World Wide Web. BMJ 1996;313:1381-4.
25. Lukasiewicz E, Martel J, Roujeau JC, Flahault A. La dermatologie libérale en France en 2000. Sondage représentatif un jour donné. Ann Dermatol Venereol 2002. Sous presse.
26. Czernichow S, Flahault A. Phone prompt or mailed reminder for increasing response rate among investigators? A randomized trial in the Sentinelles network. Rev Epidemiol Sante Publique 2000;49:93-4.